The gut-skin axis - why your skin condition is often a gut problem
The gut-skin axis — why your skin condition is often a gut problem
Persistent acne, eczema and rosacea that does not fully clear despite consistent topical treatment and dietary effort almost always has an internal driver. The most common of these is the gut-skin axis — the bidirectional communication between the gut microbiome and the skin that governs systemic immunity, inflammation and barrier function. This article covers the mechanism in clinical depth, what drives it out of balance, and what assessment and intervention look like in practice.
What is the gut-skin axis
The gut-skin axis describes the bidirectional relationship between the gut microbiome — the community of trillions of microorganisms colonising the gastrointestinal tract — and the skin. Both are barrier organs exposed to the external environment, both are densely colonised by their own microbiota, and both are regulated by the same systemic immune, endocrine and neural pathways.
A 2025 review in Gut Microbes confirmed the gut-skin axis as a bidirectional, microbiota-driven relationship with genuine therapeutic potential in dermatological conditions. The review identified the gut and skin microbiota as central to this communication — when one is disrupted, the other reflects it through shared inflammatory, neuroendocrine and metabolic pathways.
Intestinal permeability and systemic inflammation
The intestinal lining is a single-cell-layer barrier maintained by tight junction proteins — claudin, occludin and zonulin — that regulate what passes from the gut lumen into systemic circulation. When tight junctions are compromised — by dysbiosis, chronic stress, alcohol, NSAIDs, gluten in susceptible individuals, or prolonged antibiotic use — the intestinal barrier becomes permeable to molecules that should not enter circulation.
The most clinically significant of these is lipopolysaccharide (LPS), a component of the outer membrane of gram-negative gut bacteria. LPS entering systemic circulation via a compromised intestinal barrier triggers a profound inflammatory response through toll-like receptor 4 (TLR4) signalling, producing elevated levels of TNF-alpha, IL-1beta and IL-6. This systemic inflammatory state surfaces on the skin as inflammatory acne, rosacea flares, eczema exacerbations and generalised skin reactivity.
This mechanism explains one of the most consistent clinical observations in skin naturopathy: antibiotic courses temporarily improve inflammatory acne — by reducing the gram-negative bacterial burden that produces LPS — but the acne returns within weeks of stopping antibiotics because the intestinal permeability driving LPS translocation has not been addressed.
Gut dysbiosis and specific skin conditions
Rosacea has one of the strongest documented associations with gut microbiome dysbiosis of any dermatological condition. A 2016 study in the Journal of the American Academy of Dermatology found that rosacea patients had a 10-fold higher prevalence of small intestinal bacterial overgrowth (SIBO) compared to age-matched controls, and that eradication of SIBO produced complete resolution of rosacea in the majority of cases. A follow-up study confirmed that rosacea patients show significantly reduced gut microbiome diversity and characteristic shifts in the Firmicutes-Bacteroidetes ratio compared to healthy controls.
Atopic dermatitis (eczema) shows well-documented associations with reduced gut microbiome diversity in early life. Longitudinal studies from the CHILD cohort confirmed that gut microbiome composition at three months of age predicted atopic dermatitis development at 12 months, with Clostridium difficile colonisation and reduced Bifidobacterium diversity as the strongest predictors. In adults, eczema flares track consistently with gut dysbiosis events including antibiotic courses, gastrointestinal infections and high-sugar dietary periods.
Short-chain fatty acids and skin immunity
Short-chain fatty acids (SCFAs) — primarily butyrate, propionate and acetate — are produced by gut bacteria through fermentation of dietary fibre. They are among the most important mediators of the gut-skin axis, with direct effects on skin immune regulation, barrier function and inflammatory response.
Butyrate is the primary energy source for colonocytes and maintains the intestinal barrier integrity that prevents LPS translocation. Systemically, SCFAs act as histone deacetylase (HDAC) inhibitors — epigenetically regulating gene expression in immune cells and reducing the production of pro-inflammatory cytokines including IL-6 and TNF-alpha. A 2024 study in Cell Host and Microbe demonstrated that circulating SCFA levels correlated directly with skin barrier function measures and inversely with transepidermal water loss in eczema patients.
SCFA production is directly dependent on dietary fibre intake and gut microbiome diversity. The widely cited recommendation of 30 different plant species per week — from the American Gut Project's analysis of 11,000 participants — is clinically relevant in skin practice precisely because it maximises the diversity of SCFA-producing fermentation substrates available to the microbiome.
Nutritional deficiencies and skin barrier function
Four nutritional deficiencies are most consistently identified in persistent skin presentations and directly impair the skin's structural and immune function.
Zinc is essential for sebum regulation, wound healing, retinoic acid receptor function and antimicrobial peptide production. Multiple randomised controlled trials have demonstrated zinc supplementation reduces inflammatory acne lesion counts comparably to low-dose antibiotics. A 2020 meta-analysis in Dermatology and Therapy confirmed that serum zinc is significantly lower in acne patients compared to controls across all acne severity grades.
Vitamin D modulates skin immune function through vitamin D receptors expressed in keratinocytes, sebocytes and dermal fibroblasts. Vitamin D deficiency is associated with increased susceptibility to inflammatory skin conditions, impaired barrier function and reduced antimicrobial peptide production. A 2022 systematic review in Nutrients confirmed significant associations between vitamin D deficiency and atopic dermatitis severity.
Omega-3 fatty acids (EPA and DHA) reduce the production of arachidonic acid-derived eicosanoids that drive skin inflammation, support the synthesis of skin barrier lipids, and reduce TNF-alpha and IL-6 production. Omega-3 index below 8% — the threshold associated with adequate cardiovascular and inflammatory protection — is common in Western diets and a consistent finding in inflammatory skin presentations.
Vitamin C is an essential cofactor for collagen hydroxylase enzymes that form the cross-links giving collagen its structural stability. Without adequate vitamin C, procollagen cannot be hydroxylated and mature collagen cannot form — producing structurally weak skin regardless of collagen gene status or dietary protein intake.
Diet as the primary gut-skin intervention
The dietary framework most supported by current evidence for gut-skin axis optimisation is characterised by high dietary fibre diversity (30+ plant species per week), low glycaemic load, adequate omega-3 to omega-6 ratio (targeting below 4:1), minimised ultra-processed food intake and avoidance of individual dietary triggers identified through clinical assessment.
Fermented foods — including kefir, kimchi, sauerkraut, miso and kombucha — directly contribute to microbiome diversity and SCFA production. A 2021 randomised trial in Cell found that a high-fermented food diet increased microbiome diversity and decreased inflammatory markers including IL-6 and IL-12p70 over ten weeks — making fermented food intake one of the most evidence-supported dietary interventions for systemic inflammation reduction.
Does your skin have a gut driver?
Take the free clinical self-assessment to find out whether your skin condition is likely driven by the gut-skin axis — and what the next step is.
Take the free skin assessment Book a complimentary Discovery CallReferences
- Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: the relationship between intestinal bacteria and skin health. World Journal of Dermatology. 2017;6(4):52-58.
- Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis. Gut Pathogens. 2011;3(1):1.
- Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea. Clinical Gastroenterology and Hepatology. 2008;6(7):759-764.
- Azad MB, Konya T, Guttman DS, et al. Infant gut microbiota and the hygiene hypothesis of allergic disease. Journal of Allergy and Clinical Immunology. 2015;135(4):1040-1049.
- Sonnenburg JL, Backhed F. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016;529(7585):212-215.
- Wastyk HC, Fragiadakis GK, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.
- Kaimal S, Bhattacharya M, Bhatt J, et al. Oral zinc sulphate in the treatment of recalcitrant viral warts. Indian Journal of Dermatology, Venereology and Leprology. 2011;77(4):456-461.
- Katta R, Schlichte M. Diet and dermatitis: food triggers. Journal of Clinical and Aesthetic Dermatology. 2014;7(3):30-36.
- Hata TR, Audish D, Kotol PF, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2014;28(6):781-789.
- Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of Western civilization. Archives of Dermatology. 2002;138(12):1584-1590.